anti-Tumor Necrosis Factor Receptor Superfamily, Member 8 (TNFRSF8) Anticorps

The protein encoded by TNFRSF8 is a member of the TNF-receptor superfamily. De plus, nous expédions TNFRSF8 Kits (34) et TNFRSF8 Protéines (21) et beaucoup plus de produits pour cette protéine.

afficher tous les anticorps Gène GeneID UniProt
TNFRSF8 943 P28908
TNFRSF8 21941 Q60846
TNFRSF8 25069 P97525
Comment commander chez anticorps-enligne
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Commandez enligne
  • orders@anticorps-enligne.fr

Top anti-TNFRSF8 Anticorps sur anticorps-enligne.fr

Showing 10 out of 696 products:

Catalogue No. Reactivité Hôte Conjugué Application Images Quantité Fournisseur Livraison Prix Détails
Humain Lapin Inconjugué WB Anti-CD30 Picoband antibody,  All lanes: Anti-CD30 at 0.5ug/ml Lane 1: HELA Whole Cell Lysate at 40ug Lane 2: 293T Whole Cell Lysate at 40ug Lane 3: JURKAT Whole Cell Lysate at 40ug Predicted bind size: 67KD Observed bind size: 67KD 100 μg Connectez-vous pour afficher 4 to 6 Days
$200.00
Détails
Souris Hamster FITC FACS 0.5 mg Connectez-vous pour afficher 6 to 8 Days
$379.50
Détails
Humain Souris Inconjugué EIA, FACS, IHC (fro), IHC (p), IP, WB   0.1 mg Connectez-vous pour afficher 6 to 8 Days
$423.50
Détails
Humain Souris FITC FACS 50 μg Connectez-vous pour afficher 6 to 8 Days
$346.50
Détails
Humain Lapin Inconjugué ELISA, IHC (p), IP, WB 100 μg Connectez-vous pour afficher 20 to 21 Days
$218.90
Détails
Souris Rat PE FACS   100 Tests Connectez-vous pour afficher 6 to 8 Days
$313.50
Détails
Souris Hamster Biotin FACS   0.5 mg Connectez-vous pour afficher 6 to 8 Days
$379.50
Détails
Humain Souris Inconjugué FACS, ELISA, WB Figure 1: Red: Control Antigen (100 ng), Purple: Antigen (10ng), Green: Antigen (50 ng), Blue: Antigen (100 ng) Figure 2: Flow cytometric analysis of Hela cells using CD30 mouse mAb (green) and negative control (red) . 100 μL Connectez-vous pour afficher 2 to 3 Days
$430.10
Détails
Humain Lapin FITC IF (p) Raji probed with CD30 Polyclonal Antibody, FITC Conjugated (bs-2495R-FITC) at 1:100 for 30 minutes compared to control cells (blue) and isotype control (orange). 100 μL Connectez-vous pour afficher 14 to 21 Days
$405.90
Détails
Humain Souris Inconjugué FACS, IHC (p) Human Thymus (formalin-fixed, paraffin-embedded) stained with TNFRSF8 antibody LS-B1865 at 5 ug/ml followed by biotinylated anti-mouse IgG secondary antibody LS-D2, alkaline phosphatase-streptavidin and chromogen. 0.1 mg Connectez-vous pour afficher 5 to 7 Days
$242.55
Détails

TNFRSF8 Anticorps par réactivité, application, clonalité et conjugué

Attributs Application Hôte Clonalité Conjugué
Human , , , ,
, ,
,
, , , , , , , , , , , , , , , , , , ,
Mouse (Murine) , , , ,
, , ,
,
, , , , , , , , , , , , , , , , , , ,
Rat (Rattus) , ,


, , , , , , , , , , , , ,

anti-TNFRSF8 Anticorps mieux référencés

  1. Mouse (Murine) Monoclonal TNFRSF8 Primary Antibody pour FACS - ABIN2689176 : Amakawa, Hakem, Kundig, Matsuyama, Simard, Timms, Wakeham, Mittruecker, Griesser, Takimoto, Schmits, Shahinian, Ohashi, Penninger, Mak: Impaired negative selection of T cells in Hodgkin's disease antigen CD30-deficient mice. dans Cell 1996 (PubMed)
    Show all 12 Pubmed References

  2. Human Monoclonal TNFRSF8 Primary Antibody pour IHC (f), FACS - ABIN2749181 : Aalberse, Kapitein, de Roock, Klein, de Jager, van der Zee, Hoekstra, van Wijk, Prakken: Cord blood CD4+ T cells respond to self heat shock protein 60 (HSP60). dans PLoS ONE 2011 (PubMed)
    Show all 5 Pubmed References

  3. Human Monoclonal TNFRSF8 Primary Antibody pour IHC (f), FACS - ABIN2749180 : Franke, Jung, Ellis: Characterization of the CD30L binding domain on the human CD30 molecule using anti-CD30 antibodies. dans Hybridoma 2000 (PubMed)
    Show all 5 Pubmed References

  4. Human Monoclonal TNFRSF8 Primary Antibody pour FACS - ABIN610027 : Dayanir, Meyer, Lashkari, Rahimi: Identification of tyrosine residues in vascular endothelial growth factor receptor-2/FLK-1 involved in activation of phosphatidylinositol 3-kinase and cell proliferation. dans The Journal of biological chemistry 2001 (PubMed)
    Show all 2 Pubmed References

  5. Human Monoclonal TNFRSF8 Primary Antibody pour FACS - ABIN4900897 : Cocco, Stephenson, Care, Newton, Barnes, Davison, Rawstron, Westhead, Doody, Tooze: In vitro generation of long-lived human plasma cells. dans Journal of immunology (Baltimore, Md. : 1950) 2012 (PubMed)
    Show all 2 Pubmed References

  6. Human Monoclonal TNFRSF8 Primary Antibody pour FACS, ELISA - ABIN969019 : Kamali, Abbasi, Farokhi, Abbasi, Fallah, Seifee, Ghadimi, Rezaie: Posttransplant soluble CD30 as a predictor of acute renal allograft rejection. dans Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 2010 (PubMed)

  7. Human Monoclonal TNFRSF8 Primary Antibody pour FACS, IHC (p) - ABIN192353 : Pavlov, Martins, Delgado: Development and validation of a fluorescent microsphere immunoassay for soluble CD30 testing. dans Clinical and vaccine immunology : CVI 2009 (PubMed)
    Show all 7 Pubmed References

  8. Human Monoclonal TNFRSF8 Primary Antibody pour FACS, IHC (p) - ABIN192354 : Wright, Rumble, Duckett: CD30 activates both the canonical and alternative NF-kappaB pathways in anaplastic large cell lymphoma cells. dans The Journal of biological chemistry 2007 (PubMed)
    Show all 7 Pubmed References

  9. Human Monoclonal TNFRSF8 Primary Antibody pour FACS, IHC (p) - ABIN192355 : Zeiser, Nguyen, Hou, Beilhack, Zambricki, Buess, Contag, Negrin: Early CD30 signaling is critical for adoptively transferred CD4+CD25+ regulatory T cells in prevention of acute graft-versus-host disease. dans Blood 2007 (PubMed)
    Show all 7 Pubmed References

  10. Human Monoclonal TNFRSF8 Primary Antibody pour FACS, IHC (p) - ABIN94067 : Polte, Behrendt, Hansen: Direct evidence for a critical role of CD30 in the development of allergic asthma. dans The Journal of allergy and clinical immunology 2006 (PubMed)
    Show all 7 Pubmed References

Plus d’anticorps contre TNFRSF8 partenaires d’interaction

Human Tumor Necrosis Factor Receptor Superfamily, Member 8 (TNFRSF8) interaction partners

  1. Variant histology is common in pediatric NLPHL, especially types C and E, which are associated with IgD expression. Type C variant histology and possibly type D are associated with decreased EFS (Montrer EFS Anticorps), but neither IgD nor CD30 are adverse features. Variant histology may warrant increased surveillance, but did not affect overall survival.

  2. Expression of CD30 in patients with both DLBCL and other aggressive B-cell lymphomas and the absence of MYC (Montrer MYC Anticorps) oncogene (Montrer RAB1A Anticorps)-driven proliferation in the majority of these tumors suggests that brentuximab may be a particularly effective form of targeted therapy in the subset of patients with high CD30 expression.

  3. Prevalence of the CD30 (Ki-1) antigen in human solid tumors was summarized.

  4. CD30 expression was detected in up to 25% of cases of diffuse large B-cell lymphoma and was more frequent in tumors without MYC (Montrer MYC Anticorps) rearrangement. CD30 expression was not associated with overall survival in R-EPOCH-treated de novo DLBCL patients.

  5. CD30 facilitates phosphorylation of heat shock factor 1, activates heat shock promoter element, and induces heat shock protein (HSP) 90 (Montrer HSP90AA1 Anticorps).

  6. this study shows that polyclonal and allogeneic stimulation induced higher levels of CD30 transcripts in end-stage renal disease patients compared to control patients

  7. CD30 expression was not associated with prognosis in our cohort of de novoDLBCL, including in patients who received aggressive chemotherapy. CD30 expression and MYC (Montrer MYC Anticorps) rearrangement were mutually exclusive in de novoDLBCL.

  8. Case Report: CD30 positive lymphomatoid papulosis arising in association with cutaneous amyloidosis in a patient with multiple myeloma.

  9. The heterogeneity of CD30 expression in refractory or relapsed peripheral T-cell lymphoma patients indicates the likelihood for better response for patients with strong CD30 expression by tumor cells.

  10. CD30 may be useful as a prognostic marker in rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP (Montrer DDIT3 Anticorps)) treated DLBCLs, indicating favorable outcomes in a Chinese population.

Mouse (Murine) Tumor Necrosis Factor Receptor Superfamily, Member 8 (TNFRSF8) interaction partners

  1. This study demonstrated the amelioration of MOG35-55 peptide-induced active EAE in CD30 KO mice. CD30 was expressed limitedly on CD4 (Montrer CD4 Anticorps) T cells at the induction phase of experimental autoimmune encephalomyelitis.

  2. Data indicate that CD30L (Montrer TNFSF8 Anticorps)/CD30 axis plays a modulatory role in the pathogenesis of experimental autoimmune encephalomyelitis (EAE).

  3. role in the maintenance and activation of IL-17A (Montrer IL17A Anticorps)-producing gammadelta T cells

  4. These results suggest that CD30 signaling plays an important role in the activation of IL-17A (Montrer IL17A Anticorps)-producing Vgamma1(-) Vgamma4(-) gammadelta T cells bearing Vgamma6 at an early stage of BCG (Montrer SLC11A1 Anticorps) infection.

  5. Interference of the CD30-CD30L (Montrer TNFSF8 Anticorps) pathway reduces atherosclerosis development.

  6. CD30L (Montrer TNFSF8 Anticorps)/CD30 pathway acts as an accelerator of enteritis in a murine disease model

  7. role of CD30L (Montrer TNFSF8 Anticorps)/CD30 interactions in allergic rhinitis; results suggest that CD30L (Montrer TNFSF8 Anticorps) plays an important role in allergic rhinitis

  8. Abrogation of CD30 and OX40 (Montrer TNFRSF4 Anticorps) signals prevents autoimmune disease in FoxP3 (Montrer FOXP3 Anticorps)-deficient mice.

  9. Studies demonstrate that CD30L (Montrer TNFSF8 Anticorps)/CD30 signaling executed by the T-T cell interaction plays a critical role in Th17 cell differentiation.

  10. CD30 can signal in a completely TCR-independent fashion to induce IL-13 (Montrer IL13 Anticorps) production by effector T cells.

TNFRSF8 profil antigène

Profil protéine

The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor is expressed by activated, but not by resting, T and B cells. TRAF2 and TRAF5 can interact with this receptor, and mediate the signal transduction that leads to the activation of NF-kappaB. This receptor is a positive regulator of apoptosis, and also has been shown to limit the proliferative potential of autoreactive CD8 effector T cells and protect the body against autoimmunity. Two alternatively spliced transcript variants of this gene encoding distinct isoforms have been reported.

Gene names and symbols associated with TNFRSF8

  • TNF receptor superfamily member 8 (TNFRSF8) anticorps
  • tumor necrosis factor receptor superfamily, member 8 (Tnfrsf8) anticorps
  • TNF receptor superfamily member 8 (Tnfrsf8) anticorps
  • TNF superfamily member 8 (TNFSF8) anticorps
  • Cd30 anticorps
  • D1S166E anticorps
  • Ki anticorps
  • Ki-1 anticorps
  • TNFRSF8 anticorps

Protein level used designations for TNFRSF8

CD30L receptor , Ki-1 antigen , cytokine receptor CD30 , lymphocyte activation antigen CD30 , tumor necrosis factor receptor superfamily member 8 , Tumor necrosis factor superfamily member 8 , tumor necrosis factor superfamily, member CD30 , tumor necrosis factor receptor superfamily, member 8 , tumor necrosis factor ligand superfamily member 8 , tumor necrosis factor receptor superfamily member 8-like

GENE ID SPECIES
943 Homo sapiens
21941 Mus musculus
25069 Rattus norvegicus
395090 Gallus gallus
457960 Pan troglodytes
487438 Canis lupus familiaris
574055 Sus scrofa
574056 Bos taurus
614780 Bos taurus
722773 Macaca mulatta
100385465 Callithrix jacchus
100579424 Nomascus leucogenys
Fournisseurs de qualité sélectionnés pour anti-TNFRSF8 (TNFRSF8) Anticorps
Avez-vous cherché autre chose?